BPMC
UBS Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278M | Buy |
2,167,028
+1,953,223
| +914% | +$250M | 0.05% | 330 |
|
|
2025
Q1 | $18.9M | Buy |
213,805
+16,345
| +8% | +$1.45M | ﹤0.01% | 1830 |
|
|
2024
Q4 | $17.2M | Buy |
197,460
+79,904
| +68% | +$6.97M | ﹤0.01% | 1883 |
|
|
2024
Q3 | $10.9M | Buy |
117,556
+32,933
| +39% | +$3.05M | ﹤0.01% | 1617 |
|
|
2024
Q2 | $9.12M | Sell |
84,623
-40,812
| -33% | -$4.4M | ﹤0.01% | 1666 |
|
|
2024
Q1 | $11.9M | Sell |
125,435
-1,103
| -0.9% | -$105K | ﹤0.01% | 1506 |
|
|
2023
Q4 | $11.7M | Buy |
126,538
+61,486
| +95% | +$5.67M | ﹤0.01% | 1374 |
|
|
2023
Q3 | $3.27M | Sell |
65,052
-16,714
| -20% | -$839K | ﹤0.01% | 2169 |
|
|
2023
Q2 | $5.17M | Sell |
81,766
-2,907
| -3% | -$184K | ﹤0.01% | 1879 |
|
|
2023
Q1 | $3.81M | Sell |
84,673
-50,185
| -37% | -$2.26M | ﹤0.01% | 2061 |
|
|
2022
Q4 | $5.91M | Buy |
134,858
+125,458
| +1,335% | +$5.5M | ﹤0.01% | 1706 |
|
|
2022
Q3 | $619K | Sell |
9,400
-23,848
| -72% | -$1.57M | ﹤0.01% | 3203 |
|
|
2022
Q2 | $1.68M | Sell |
33,248
-15,055
| -31% | -$761K | ﹤0.01% | 2513 |
|
|
2022
Q1 | $3.09M | Sell |
48,303
-16,018
| -25% | -$1.02M | ﹤0.01% | 2329 |
|
|
2021
Q4 | $6.89M | Buy |
64,321
+11,617
| +22% | +$1.24M | ﹤0.01% | 1825 |
|
|
2021
Q3 | $5.42M | Buy |
52,704
+32,101
| +156% | +$3.3M | ﹤0.01% | 1932 |
|
|
2021
Q2 | $1.81M | Sell |
20,603
-44,510
| -68% | -$3.91M | ﹤0.01% | 2813 |
|
|
2021
Q1 | $6.33M | Buy |
65,113
+47,436
| +268% | +$4.61M | ﹤0.01% | 1770 |
|
|
2020
Q4 | $1.98M | Buy |
17,677
+12,178
| +221% | +$1.37M | ﹤0.01% | 2638 |
|
|
2020
Q3 | $510K | Sell |
5,499
-3,254
| -37% | -$302K | ﹤0.01% | 3414 |
|
|
2020
Q2 | $683K | Buy |
8,753
+4,687
| +115% | +$366K | ﹤0.01% | 3141 |
|
|
2020
Q1 | $238K | Sell |
4,066
-20,300
| -83% | -$1.19M | ﹤0.01% | 3768 |
|
|
2019
Q4 | $1.95M | Sell |
24,366
-35,564
| -59% | -$2.85M | ﹤0.01% | 2779 |
|
|
2019
Q3 | $4.4M | Buy |
59,930
+59,370
| +10,602% | +$4.36M | ﹤0.01% | 1952 |
|
|
2019
Q2 | $53K | Buy |
560
+225
| +67% | +$21.3K | ﹤0.01% | 5009 |
|
|
2019
Q1 | $27K | Sell |
335
-33,799
| -99% | -$2.72M | ﹤0.01% | 5206 |
|
|
2018
Q4 | $1.84M | Buy |
34,134
+11,288
| +49% | +$609K | ﹤0.01% | 2510 |
|
|
2018
Q3 | $1.78M | Buy |
22,846
+22,456
| +5,758% | +$1.75M | ﹤0.01% | 2697 |
|
|
2018
Q2 | $25K | Sell |
390
-56,428
| -99% | -$3.62M | ﹤0.01% | 5613 |
|
|
2018
Q1 | $5.21M | Buy |
56,818
+39,774
| +233% | +$3.65M | ﹤0.01% | 1821 |
|
|
2017
Q4 | $1.29M | Sell |
17,044
-16,391
| -49% | -$1.24M | ﹤0.01% | 2836 |
|
|
2017
Q3 | $2.33M | Buy |
33,435
+10,594
| +46% | +$738K | ﹤0.01% | 2378 |
|
|
2017
Q2 | $1.16M | Buy |
22,841
+15,513
| +212% | +$786K | ﹤0.01% | 2806 |
|
|
2017
Q1 | $293K | Sell |
7,328
-5,501
| -43% | -$220K | ﹤0.01% | 3609 |
|
|
2016
Q4 | $360K | Buy |
12,829
+9,514
| +287% | +$267K | ﹤0.01% | 3538 |
|
|
2016
Q3 | $98K | Buy |
3,315
+415
| +14% | +$12.3K | ﹤0.01% | 4158 |
|
|
2016
Q2 | $58K | Sell |
2,900
-5,901
| -67% | -$118K | ﹤0.01% | 4559 |
|
|
2016
Q1 | $158K | Buy |
8,801
+329
| +4% | +$5.91K | ﹤0.01% | 3935 |
|
|
2015
Q4 | $223K | Buy |
8,472
+121
| +1% | +$3.19K | ﹤0.01% | 3698 |
|
|
2015
Q3 | $178K | Buy |
8,351
+526
| +7% | +$11.2K | ﹤0.01% | 3783 |
|
|
2015
Q2 | $207K | Buy |
+7,825
| New | +$207K | ﹤0.01% | 3844 |
|